PURPOSE: To visualize and quantify the size and vessel density of macular neovascularization (MNV) using optical coherence tomography angiography (OCTA) with a projection artifact removal algorithm. DESIGN: Multicenter, observational study. PARTICIPANTS: Subjects with MNV in at least one eye. METHODS: Patients were imaged using either a swept-source OCT angiography (SS-OCTA) prototype system or a spectral-domain OCT angiography (SD-OCTA) prototype system. The optical microangiography (OMAG) algorithm was used to generate the OCTA images. Projection artifacts from the overlying retinal circulation were removed from the OMAG OCTA images using a novel algorithm. Following removal of the projection artifacts from the OCTA images, we assessed the size and vascularity of the MNV. Concurrent fluorescein angiography (FA) and indocyanine green angiography (ICGA) images were used to validate the artifact-free OMAG images whenever available. MAIN OUTCOME MEASURES: Size and vascularity of MNV imaged with OCTA before and after the use of a projection-artifact removal algorithm. RESULTS: A total of 30 subjects (40 eyes) diagnosed with MNV were imaged. Five patients were imaged before and after intravitreal injections of vascular endothelial growth factor (VEGF) inhibitors. Following the use of the projection artifact removal algorithm, we found improved visualization of the MNV. Lesion sizes and vascular densities were more easily measured on all the artifact-free OMAG images. In eyes treated with vascular endothelial growth factor inhibitors, vascular density was reduced in all five eyes after treatment, and in four eyes, the size of the MNV decreased. One of five patients showed a slight increase in lesion size, but a decrease in vascular density. CONCLUSIONS: OCTA imaging of MNV using the OMAG algorithm combined with removal of projection artifacts resulted in improved visualization and measurements of the neovascular lesions. OMAG with projection artifact removal should be useful for assessing the response of MNV to treatment using OCTA imaging.
PURPOSE: To visualize and quantify the size and vessel density of macular neovascularization (MNV) using optical coherence tomography angiography (OCTA) with a projection artifact removal algorithm. DESIGN: Multicenter, observational study. PARTICIPANTS: Subjects with MNV in at least one eye. METHODS:Patients were imaged using either a swept-source OCT angiography (SS-OCTA) prototype system or a spectral-domain OCT angiography (SD-OCTA) prototype system. The optical microangiography (OMAG) algorithm was used to generate the OCTA images. Projection artifacts from the overlying retinal circulation were removed from the OMAG OCTA images using a novel algorithm. Following removal of the projection artifacts from the OCTA images, we assessed the size and vascularity of the MNV. Concurrent fluorescein angiography (FA) and indocyanine green angiography (ICGA) images were used to validate the artifact-free OMAG images whenever available. MAIN OUTCOME MEASURES: Size and vascularity of MNV imaged with OCTA before and after the use of a projection-artifact removal algorithm. RESULTS: A total of 30 subjects (40 eyes) diagnosed with MNV were imaged. Five patients were imaged before and after intravitreal injections of vascular endothelial growth factor (VEGF) inhibitors. Following the use of the projection artifact removal algorithm, we found improved visualization of the MNV. Lesion sizes and vascular densities were more easily measured on all the artifact-free OMAG images. In eyes treated with vascular endothelial growth factor inhibitors, vascular density was reduced in all five eyes after treatment, and in four eyes, the size of the MNV decreased. One of five patients showed a slight increase in lesion size, but a decrease in vascular density. CONCLUSIONS:OCTA imaging of MNV using the OMAG algorithm combined with removal of projection artifacts resulted in improved visualization and measurements of the neovascular lesions. OMAG with projection artifact removal should be useful for assessing the response of MNV to treatment using OCTA imaging.
Authors: Nora W Muakkassa; Adam T Chin; Talisa de Carlo; Kendra A Klein; Caroline R Baumal; Andre J Witkin; Jay S Duker; Nadia K Waheed Journal: Retina Date: 2015-11 Impact factor: 4.256
Authors: Yanping Huang; Qinqin Zhang; Mariana R Thorell; Lin An; Mary K Durbin; Michal Laron; Utkarsh Sharma; Giovanni Gregori; Philip J Rosenfeld; Ruikang K Wang Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2014 Sep-Oct Impact factor: 1.300
Authors: Talisa E de Carlo; Marco A Bonini Filho; Adam T Chin; Mehreen Adhi; Daniela Ferrara; Caroline R Baumal; Andre J Witkin; Elias Reichel; Jay S Duker; Nadia K Waheed Journal: Ophthalmology Date: 2015-03-17 Impact factor: 12.079
Authors: Jin Yang; Qinqin Zhang; Elie H Motulsky; Marie Thulliez; Yingying Shi; Cancan Lyu; Luis de Sisternes; Mary K Durbin; William Feuer; Ruikang K Wang; Giovanni Gregori; Philip J Rosenfeld Journal: Am J Ophthalmol Date: 2019-06-21 Impact factor: 5.258
Authors: Yingying Shi; Qinqin Zhang; Fang Zheng; Jonathan F Russell; Elie H Motulsky; James T Banta; Zhongdi Chu; Hao Zhou; Nimesh A Patel; Luis de Sisternes; Mary K Durbin; William Feuer; Giovanni Gregori; Ruikang K Wang; Philip J Rosenfeld Journal: Am J Ophthalmol Date: 2019-09-25 Impact factor: 5.258
Authors: Ian C Holmen; Sri Meghana Konda; Jeong W Pak; Kyle W McDaniel; Barbara Blodi; Kimberly E Stepien; Amitha Domalpally Journal: JAMA Ophthalmol Date: 2020-02-01 Impact factor: 7.389
Authors: Yingying Shi; Zhongdi Chu; Liang Wang; Qinqin Zhang; William Feuer; Luis de Sisternes; Mary K Durbin; Giovanni Gregori; Ruikang K Wang; Philip J Rosenfeld Journal: Am J Ophthalmol Date: 2020-07-02 Impact factor: 5.258
Authors: Fang Zheng; Qinqin Zhang; Yingying Shi; Jonathan F Russell; Elie H Motulsky; James T Banta; Zhongdi Chu; Hao Zhou; Nimesh A Patel; Luis de Sisternes; Mary K Durbin; William Feuer; Giovanni Gregori; Ruikang Wang; Philip J Rosenfeld Journal: Am J Ophthalmol Date: 2019-01-09 Impact factor: 5.258